{
    "root": "039dfe2e-cc30-42ed-9444-cffd6324a9bd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Aripiprazole",
    "value": "20250317",
    "ingredients": [
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "TARTARIC ACID",
            "code": "W4888I119H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "FD&C BLUE NO. 2 ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "INDIGOTINDISULFONATE SODIUM",
            "code": "D3741U8K7L",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11577"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C RED NO. 40 ALUMINUM LAKE",
            "code": "6T47AS764T"
        }
    ],
    "indications": {
        "text": "aripiprazole oral tablets indicated treatment : \u2022schizophrenia \u2022irritability associated autistic disorder \u2022treatment tourette \u2019 disorder",
        "doid_entities": [
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "initial dose recommended dose maximum dose schizophrenia \u2013 adults ( 2.1 ) 10 15 mg/day 10 15 mg/day 30 mg/day schizophrenia \u2013 adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day irritability associated autistic disorder \u2013 pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15 mg/day tourette \u2019 disorder \u2013 ( 2.5 ) patients < 50 kg 2 mg/day 5 mg/day 10 mg/day patients \u226550 kg 2 mg/day 10 mg/day 20 mg/day \u2022 oral formulations : administer daily without regard meals . ( 2 ) \u2022 known cyp2d6 poor metabolizers : half usual dose . ( 2.7 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "autistic disorder (DOID:12849)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12849"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "aripiprazole tablets contraindicated patients history hypersensitivity reaction aripiprazole . ranged pruritus/urticaria anaphylaxis [ ( 6.2 ) ] .",
    "indications_original": "Aripiprazole Oral Tablets are indicated for the treatment of: \n                  \n                     \n                        \u2022Schizophrenia \n                     \n                        \u2022Irritability Associated with Autistic Disorder \n                     \n                        \u2022Treatment of Tourette\u2019s Disorder",
    "contraindications_original": "Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia \u2013 adolescents (2.1) 2 mg/day 10 mg/day 30 mg/day Irritability associated with autistic disorder \u2013 pediatric patients (2.4) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette\u2019s disorder \u2013 (2.5) Patients <50 kg 2 mg/day 5 mg/day 10 mg/day Patients \u226550 kg 2 mg/day 10 mg/day 20 mg/day \u2022 Oral formulations: Administer once daily without regard to meals. ( 2 ) \u2022 Known CYP2D6 poor metabolizers: Half of the usual dose. ( 2.7 )",
    "adverseReactions_original": "Aripiprazole tablets are contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis [see \u00a0Adverse Reactions (6.2)].",
    "drug": [
        {
            "name": "Aripiprazole",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31236"
        }
    ]
}